FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 330:811-815 March 24, 1994 Number 12 Next

	Full Text Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

ABSTRACT

Background Ulcerative colitis is largely a disease of nonsmokers. Because anecdotal reports suggest that smoking and nicotine may improve the symptoms of the disease, we examined the effect of nicotine as a supplemental treatment for ulcerative colitis.

Methods We treated 72 patients with active ulcerative colitis with either transdermal nicotine patches or placebo patches for six weeks in a randomized, double-blind study. Incremental doses of nicotine were given; most patients tolerated doses of 15 to 25 mg per 24 hours. All the patients had been taking mesalamine, and 12 were receiving low doses of glucocorticoids; these medications were continued without change during the study. Clinical, sigmoidoscopic, and histologic assessments were made at base line and at the end of the study; symptoms were recorded daily on a diary card, and the clinician made a global assessment. Side effects and plasma nicotine and cotinine concentrations were monitored throughout the study.

Results Seventeen of the 35 patients in the nicotine group had complete remissions, as compared with 9 of the 37 patients in the placebo group (P = 0.03). The patients in the nicotine group had greater improvement in the global clinical grade of colitis (P<0.001) and the histologic grade (P = 0.03), lower stool frequency (a difference of 1.6 stools daily; P = 0.008), less abdominal pain (P = 0.05), and less fecal urgency (P = 0.009). More patients in the nicotine group had side effects (23, vs. 11 in the placebo group; P = 0.002), the most common of which were nausea, lightheadedness, headache, and sleep disturbance. Withdrawals due to ineffective therapy were more common in the placebo group (3 vs. 8, P = 0.12).

Conclusions The addition of transdermal nicotine to conventional maintenance therapy improves symptoms in patients with ulcerative colitis.

Source Information

From the Department of Gastroenterology, University Hospital of Wales, Cardiff, United Kingdom (R.D.P., J.R., G.A.O.T.); Leigh Infirmary, Leigh, Greater Manchester, United Kingdom (S.G., V.M.); Princess of Wales Hospital, Bridgend, Mid Glamorgan, United Kingdom (J.S.M.); the Departments of Pathology (G.T.W.) and Medical Computing and Statistics (R.G.N.), University of Wales College of Medicine, Cardiff, United Kingdom; the Health Behaviour Unit, Institute of Psychiatry and Maudsley Hospital, London (M.A.H.R.); the Nicotine Laboratory, Poisons Unit, New Cross Hospital, London (C.F.); and Kabi Pharmacia Therapeutics, Helsingborg, Sweden (U.S.).

Address reprint requests to Dr. Rhodes at the Dept. of Gastroenterology, Ward A7, University Hospital of Wales, Heath Park, Cardiff, United Kingdom.

Full Text of this Article

This article has been cited by other articles:

• Nizri, E., Irony-Tur-Sinai, M., Lory, O., Orr-Urtreger, A., Lavi, E., Brenner, T. (2009). Activation of the Cholinergic Anti-Inflammatory System by Nicotine Attenuates Neuroinflammation via Suppression of Th1 and Th17 Responses. J. Immunol. 183: 6681-6688 [Abstract] [Full Text]  
• Chatterjee, P. K., Al-Abed, Y., Sherry, B., Metz, C. N. (2009). Cholinergic agonists regulate JAK2/STAT3 signaling to suppress endothelial cell activation. Am. J. Physiol. Cell Physiol. 297: C1294-C1306 [Abstract] [Full Text]  
• Reichert, V., Xue, X., Bartscherer, D., Jacobsen, D., Fardellone, C., Folan, P., Kohn, N., Talwar, A., Metz, C. N. (2009). A Pilot Study To Examine the Effects of Smoking Cessation on Serum Markers of Inflammation in Women at Risk for Cardiovascular Disease. Chest 136: 212-219 [Abstract] [Full Text]  
• Garud, S., Peppercorn, M. A. (2009). Review: Ulcerative colitis: current treatment strategies and future prospects. Therapeutic Advances in Gastroenterology 2: 99-108 [Abstract]  
• Rosas-Ballina, M., Ochani, M., Parrish, W. R., Ochani, K., Harris, Y. T., Huston, J. M., Chavan, S., Tracey, K. J. (2008). Splenic nerve is required for cholinergic antiinflammatory pathway control of TNF in endotoxemia. Proc. Natl. Acad. Sci. USA 105: 11008-11013 [Abstract] [Full Text]  
• Chi, Z.-L., Hayasaka, S., Zhang, X.-Y., Cui, H.-S., Hayasaka, Y. (2007). A Cholinergic Agonist Attenuates Endotoxin-Induced Uveitis in Rats. IOVS 48: 2719-2725 [Abstract] [Full Text]  
• Cloez-Tayarani, I., Changeux, J.-P. (2007). Nicotine and serotonin in immune regulation and inflammatory processes: a perspective. J. Leukoc. Biol. 81: 599-606 [Abstract] [Full Text]  
• Furlan, R., Ardizzone, S., Palazzolo, L., Rimoldi, A., Perego, F., Barbic, F., Bevilacqua, M., Vago, L., Porro, G. B., Malliani, A. (2006). Sympathetic overactivity in active ulcerative colitis: effects of clonidine. Am. J. Physiol. Regul. Integr. Comp. Physiol. 290: R224-R232 [Abstract] [Full Text]  
• Hegazi, R. A.F., Rao, K. N., Mayle, A., Sepulveda, A. R., Otterbein, L. E., Plevy, S. E. (2005). Carbon monoxide ameliorates chronic murine colitis through a heme oxygenase 1-dependent pathway. JEM 202: 1703-1713 [Abstract] [Full Text]  
• Tracey, K. J. (2005). Fat meets the cholinergic antiinflammatory pathway. JEM 202: 1017-1021 [Abstract] [Full Text]  
• Mawdsley, J E, Rampton, D S (2005). Psychological stress in IBD: new insights into pathogenic and therapeutic implications. Gut 54: 1481-1491 [Full Text]  
• Haubitz, M, Woywodt, A, de Groot, K, Haller, H, Goebel, U (2005). Smoking habits in patients diagnosed with ANCA associated small vessel vasculitis. Ann Rheum Dis 64: 1500-1502 [Abstract] [Full Text]  
• Rubin, R. L., Hermanson, T. M., Bedrick, E. J., McDonald, J. D., Burchiel, S. W., Reed, M. D., Sibbitt, W. L. Jr. (2005). Effect of Cigarette Smoke on Autoimmunity in Murine and Human Systemic Lupus Erythematosus. Toxicol Sci 87: 86-96 [Abstract] [Full Text]  
• Saeed, R. W., Varma, S., Peng-Nemeroff, T., Sherry, B., Balakhaneh, D., Huston, J., Tracey, K. J., Al-Abed, Y., Metz, C. N. (2005). Cholinergic stimulation blocks endothelial cell activation and leukocyte recruitment during inflammation. JEM 201: 1113-1123 [Abstract] [Full Text]  
• Liu, E. S.L., Ye, Y.-N., Shin, V. Y., Yuen, S.-T., Leung, S.-Y., Wong, B. C.Y., Cho, C.-H. (2003). Cigarette smoke exposure increases ulcerative colitis-associated colonic adenoma formation in mice. Carcinogenesis 24: 1407-1413 [Abstract] [Full Text]  
• Richardson, C.E., Morgan, J.M., Jasani, B., Green, J.T., Rhodes, J., Williams, G.T., Lindstrom, J., Wonnacott, S., Peel, S., Thomas, G.A.O. (2003). Effect of smoking and transdermal nicotine on colonic nicotinic acetylcholine receptors in ulcerative colitis. QJM 96: 57-65 [Abstract] [Full Text]  
• Radford-Smith, G L, Edwards, J E, Purdie, D M, Pandeya, N, Watson, M, Martin, N G, Green, A, Newman, B, Florin, T H J (2002). Protective role of appendicectomy on onset and severity of ulcerative colitis and Crohn's disease. Gut 51: 808-813 [Abstract] [Full Text]  
• Fukada, A., Saito, H., Inui, K.-i. (2002). Transport Mechanisms of Nicotine across the Human Intestinal Epithelial Cell Line Caco-2. J. Pharmacol. Exp. Ther. 302: 532-538 [Abstract] [Full Text]  
• Jacobi, J., Jang, J. J., Sundram, U., Dayoub, H., Fajardo, L. F., Cooke, J. P. (2002). Nicotine Accelerates Angiogenesis and Wound Healing in Genetically Diabetic Mice. Am. J. Pathol. 161: 97-104 [Abstract] [Full Text]  
• Tonnessen, B. H., Severson, S. R., Hurt, R. D., Miller, V. M. (2000). Modulation of Nitric-Oxide Synthase by Nicotine. J. Pharmacol. Exp. Ther. 295: 601-606 [Abstract] [Full Text]  
• Clouse, W. D., Yamaguchi, H., Phillips, M. R., Hurt, R. D., Fitzpatrick, L. A., Moyer, T. P., Rowland, C., Schaff, H. V., Miller, V. M. (2000). Effects of transdermal nicotine treatment on structure and function of coronary artery bypass grafts. J. Appl. Physiol. 89: 1213-1223 [Abstract] [Full Text]  
• Clouse, W D., Rud, K. S, Hurt, R. D, Miller, V. M (2000). Short-term treatment with transdermal nicotine affects the function of canine saphenous veins. Vasc Med 5: 75-82 [Abstract]  
• Thomas, G. A O, Rhodes, J., Green, J. T, Richardson, C. (2000). Role of smoking in inflammatory bowel disease: implications for therapy. Postgrad. Med. J. 76: 273-279 [Abstract] [Full Text]  
• Mehta, J. N., Martin, A. G. (2000). A Case of Pemphigus Vulgaris Improved by Cigarette Smoking. Arch Dermatol 136: 15-17 [Full Text]  
• Manthorpe, R, Benoni, C, Jacobsson, L, Kirtava, Z, Larsson, A, Liedholm, R, Nyhagen, C, Tabery, H, Theander, E (2000). Lower frequency of focal lip sialadenitis (focus score) in smoking patients. Can tobacco diminish the salivary gland involvement as judged by histological examination and anti-SSA/Ro and anti-SSB/La antibodies in Sjogren's syndrome?. Ann Rheum Dis 59: 54-60 [Abstract] [Full Text]  
• Schenker, M. (1998). Respiratory Health Hazards in Agriculture. Am. J. Respir. Crit. Care Med. 158: S1-S76 [Full Text]  
• Wolf, R., Ruocco, V. (1998). Nicotine for Pyoderma Gangrenosum. Arch Dermatol 134: 1071-1072 [Full Text]  
• Peppercorn, M. A. (1998). A 66-Year-Old Woman With Ulcerative Colitis. JAMA 279: 949-953 [Full Text]  
• Hanauer, S. B. (1996). Inflammatory Bowel Disease. NEJM 334: 841-848 [Full Text]  
• Thomas, G. A.O., Rhodes, J., Mani, V., Williams, G. T., Newcombe, R. G., Russell, M. A.H., Feyerabend, C. (1995). Transdermal Nicotine as Maintenance Therapy for Ulcerative Colitis. NEJM 332: 988-992 [Abstract] [Full Text]  
• (1994). TRANSDERMAL NICOTINE MAY RELIEVE ULCERATIVE COLITIS. JWatch General 1994: 2-2 [Full Text]  
• Hanauer, S. B. (1994). Nicotine for Colitis -- The Smoke Has Not Yet Cleared. NEJM 330: 856-857 [Full Text]